Early effect of Botox-A injection into the masseter muscle of rats: functional and histological evaluation

Kiris E, Burnett JC, Kane CD, Bavari S (2014) Recent advances in botulinum neurotoxin inhibitor development. Curr Top Med Chem 14(18):2044–2061

Tan EK, Jankovic J (2000) Treating severe bruxism with botulinum toxin. J Am Dent Assoc 131:211–216

Watts MW, Tan EK, Jankovic J (1999) Bruxism and cranial-cervical dystonia: is there a relationship? Cranio 17:196–201

Molina OF, Dos Santos JJ, Nelson SJ, Grossman E (1997) Prevalence of modalities of headaches and bruxism among patients with craniomandibular disorder. Cranio 15:314–325

Santamato A, Ianieri G, Ranieri M, Megna M, Panza F, Fiore P et al (2008) Botulinum toxin type A in the treatment of sialorrhea in Parkinson’s disease. J Am Geriatr Soc 56:765–767

Seok H, Park YT, KimSG PYW (2013) Correction of post-traumatic anterior open bite by injection of botulinum toxin type A into the anterior belly of the digastric muscle: case report. J Korean Assoc Oral Maxillofac Surg 39:188–192

Kim HJ, Yum KW, Lee SS, Heo MS, Seo K (2003) Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg 29:484–489

Kim JH, Shin JH, Kim ST, Kim CY (2007) Effects of two different units of botulinum toxin type A evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plast Reconstr Surg 119:711–717

von Lindern JJ, Niederhagen B, Appel T, Bergé S, Reich RH (2001) Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 107:327–332

Ahn KY, Kim ST (2007) The change of maximum bite force after botulinum toxin type A injection for treating masseteric hypertrophy. Plast Reconstr Surg 120:1662–1666

Kolaski K, Ajizian SJ, Passmore L, Pasutharnchat N, Koman LA, Smith BP (2008) Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population. Am J Phys Med Rehabil 87(7):556–566

Park SY, Park YW, Ji YJ, Park SW, Kim SG (2015) Effects of a botulinum toxin type A injection on the masseter muscle: an animal model study. Maxillofac Plast Reconstr Surg 37:10

Tsai CY, Chiu WC, Liao YH, Tsaic CM (2009) Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle. Am J Orthod Dentofacial Orthop 135(2):142, e1-6

Kiliaridis S, Engstrom C, Thilander B (1988) Histochemical analysis of masticatory muscle in the growing rat after prolonged alteration in the consistency of the diet. Arch Oral Biol 33:187–193

Kim HC, Song JM, Kim CJ, Yoon SY, Kim IR, Park BS, Shin SH (2015) Combined effect of bisphosphonate and recombinant human bone morphogenetic protein 2 on bone healing of rat calvarial defects. Maxillofac Plast Reconstr Surg 37:16

Rafferty KL, Liu ZJ, Ye W, Navarrete AL, Nguyen TT, Salamati A, Herring SW (2012) Botulinum toxin in masticatory muscles: short- and long-term effects on muscle, bone, and craniofacial function in adult rabbits. Bone 50(3):651–662

Tsai CY, Lin YC, Su B, Yang LY, Chiu WC (2012) Masseter muscle fibre changes following reduction of masticatory function. Int J Oral Maxillofac Surg 41(3):394–399

Lee CJ, Kim SG, Kim YJ, Han JY, Choi SH, Lee SI (2007) Electrophysiologic change and facial contour following botulinum toxin A injection in square faces. Plast Reconstr Surg 120:769–778

Kim NH, Chung JH, Park RH, Park JB (2005) The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 115:919–930

Freund B, Schwartz M, Symington JM (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 57:916–920

Yu CC, Chen PKT, Chen YR (2007) Botulinum toxin A for lower facial contouring: a prospective study. Aesthetic Plast Surg 31:445–451

Matic DB, Yazdani A, Wells RG, LeeTY GBS (2007) The effects of masseter muscle paralysis on facial bone growth. J Surg Res 139:243–252

Tsai CY, Yang LY, Chen KT, Chiu WC (2010) The influence of masticatory hypofunction on developing rat craniofacial structure. Int J Oral Maxillofac Surg 39:593–598

Kiliaridis S, Mejersjo C, Thilander B (1989) Muscle function and craniofacial morphology: a clinical study in patients with myotonic dystrophy. Eur J Orthod 11:131–138

Tsai CY, Huang RY, Lee CM, Hsiao WT, Yang LY (2010) Morphologic and bony structural changes in the mandible after a unilateral injection of botulinum neurotoxin in adult rats. J Oral Maxillofac Surg 68(5):1081–1087

Picard S, Lapointe NP, Brown JP, Guertin PA (2008) Histomorphometric and densitometric changes in the femora of spinal cord transected mice. Anat Rec (Hoboken) 291:303–307

Poliachik SL, Bain SD, Threet D, Huber P, Gross TS (2010) Transient muscle paralysis disrupts bone homeostasis by rapid degradation of bone morphology. Bone 46:18–23

Warner SE, Sanford DA, Becker BA, Bain SD, Srinivasan S, Gross T (2006) Botox induced muscle paralysis rapidly degrades bone. Bone 38:257–264

Weiss A, Leinwand LA (1996) The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol 12:417–439

Schiaffino S, Reggiani C (1996) Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 76:371–423

Gedrange T, Buttner C, Schneider M, Oppitz R, Harzer W (2005) Myosin heavy chain protein and gene expression in the masseter muscle of adult patients with distal or mesial malocclusion. J Appl Genet 46:227–236

Harzer W, Worm M, Gedrange T, Schneider M, Wolf P (2007) Myosin heavy chain mRNA isoforms in masseter muscle before and after orthognathic surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:486–490

Raoul G, Rowlerson A, Sciote J, Codaccioni E, Stevens L, Maurage CA, Duhamel A, Ferri J (2011) Masseter myosin heavy chain composition varies with mandibular asymmetry. J Craniofac Surg 22(3):1093–1098

Rowlerson A, Raoul G, Daniel Y, Close J, Maurage CA, Ferri J, Sciote J (2005) Fiber-type differences in masseter muscle associated with different facial morphologies. Am J Orthod Dentofacial Orthop 127(1):37–46

Borodic GE, Ferrante R, Pearce LB, Smith K (1994) Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. MovDisord 9:31–39

Bobinac D, Malnar-Dragojevic D, Bajek S, Soic-Vranic T, Jerkovic R (2000) Muscle fiber type composition and morphometric properties of denervated rat extensor digitorum longus muscle. Croat Med J 41:294–297

Del Gaudio JM, Sciote JJ (1997) Changes in myosin expression in denervated laryngeal muscle. Ann Otol Rhinol Laryngol 106:1076–1081

Gedrange T, Luck O, Hesske G, Buttner C, Seibel P, Harzer W (2001) Differential expression of myosin heavy-chain mRNA in muscles of mastication during functional advancement of the mandible in pigs. Arch Oral Biol 46:215–220

Gedrange T, Gredes T, Spassov A, Mai R, Kuhn DU, Dominiak M et al (2013) Histological changes and changes in the myosin mRNA content of the porcine masticatory muscles after masseter treatment with botulinum toxin A. Clin Oral Investig 17(3):887–896

Cao R, Huang F, Wang P, Chen C, Zhu G, Chen L et al (2015) Chronic sleep deprivation alters the myosin heavy chain isoforms in the masseter muscle in rats. Br J Oral Maxillofac Surg 53(5):430–435

Eriksson PO, Thornell LE (1983) Histochemical and morphological muscle-fibre characteristics of the human masseter, the medial pterygoid and the temporal muscles. Arch Oral Biol 28:781–795